ArticleMolecular therapy oncolytics2019

Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1.

Yujie Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.